Patent Backlog Spurs Demand for Examiners (Washington Post)
Got a degree in engineering, chemistry or physics and looking for work? The U.S. Patent and Trademark Office is hiring.
Patent Promises Personal TV Censor (DesignTechnica)
If you want to filter TV programming on something other than ratings (or the fact a show is on CBS), a new patent might promise just what you’re after.
MP3 patent suit could affect hundreds of companies (East Bay Business Times)
A patent infringement suit that could affect hundreds of companies that rely on MP3 is being heard in federal court in San Diego.
US activists try to deliver coffin to Novartis over Indian patent case (AFP via Yahoo! News)
Non-governmental groups tried to deliver a mini coffin to Swiss pharmaceuticals giant Novartis to protest legal action aiming to overturn a ban on a drug patent application in India.
Battle Pits Patent Rights Against Low-Cost Generic Drugs (New York Times)
The supply of low-cost generic versions of cancer and AIDS treatments for the developing world could be blocked if Novartis wins a legal challenge to India?s patent law.
Microsoft backpedals on programming patent (CNET)
Company says it was a “mistake” to try to patent a programming idea already used in BlueJ Java project.
US Patent Office To Re-Examine Blackboard Patent (Slashdot)
Mr_5tein writes “Groklaw is reporting that the US Patent and Trademark Office has just ordered a re-examination of the e-learning patent owned by Blackboard Inc, thanks to a filing by the Software Freedom Law Center. SFLC’s press release states, ‘The Patent Office found that prior art cited in SFLC’s request raises “a substantial new question of patentability” regarding all 44 claims of …
Ciphergen gets EU patent on prostate cancer diagnosis (bizjournals.com via Yahoo! Finance)
Ciphergen Biosystems Inc. said Thursday the European Patent Office issued the company a patent covering a method for aiding prostate cancer diagnosis.
AP Interview: Novartis to offer cancer drug for free even if it wins patent case in India (Associated Press via Yahoo! India News)
Swiss pharmaceutical giant Novartis AG will continue to offer its leukemia drug for free to patients who cannot afford it even the company wins a patent dispute in India, a senior company executive said Friday.
ADMD: Licences Patent for Alpha-Emitting Radionuclide Actinium-225 (Nasdaq)
Advanced Medical Isotopes Corporation’s (ADMD) Chief Executive Officer, William Stokes, is pleased to announce the licensing of United States Patent 6,680,993. Stokes said, “This patent is involved with the methods and processes directed to the preparation of Actinium-225 and daughters having high radiochemical and radionuclidic purity, which may be used for the preparation of …
You are currently browsing the Patent Search and Filing weblog archives for January, 2007.
